Recently, mutations in RYR1 and TTN, the genes encoding skeletal muscle RyR and the cytoskeletal protein titin, respectively, have also been implicated in the development of a CNM phenotype providing greater evidence for the involvement of Ca2+ in CNM pathogenesis [169,170]. The gene discussed is DNM2; the disease is centronuclear myopathy.